Weight loss or fat loss can be quite a challenge, especially if the traditional methods are not helping you decrease your weight on the scale. Your body's resistance to expelling unwanted fat following both a controlled diet and exercise program is quite often attributed to a medical issue or a condition like obesity. If your situation is a pre-existing condition that is hindering your weight loss, your doctor can prescribe a medical intervention like a weight loss drug. Wegovy and Ozempic are two drugs that can accelerate fat loss, helping you achieve and maintain a healthy weight.
How Does Wegovy Reach Successful Results?
Wegovy is an FDA approved drug for adults with obesity, or a BMI over 30 and overweight adults with excess weight-BMI over 27, who also have weight-related medical issues.
Wegovy is an injectable drug created by Nova Nordisk. It is an FDA-approved drug specifically created for chronic weight management. It can be used if you have obesity or weight-related medical conditions. Wegovy uses the active ingredient semaglutide to facilitate weight loss and by mirroring the function of GLP-1, a hormone that occurs naturally in your body.
With your injection, Wegovy regulates your food intake and delays the gastric emptying making you feel full longer. This leads to a decreased appetite and fewer cravings, which then encourages weight loss. The drug also stimulates natural insulin release, which controls your blood sugar spike after a meal. In collaboration with a controlled diet and an increase in exercise, this approach is effective and safe.
This approach does not force your body to burn fat. Rather, it manipulates your natural body processes to encourage your body to eliminate fat. You should see visible results within the time limits specified by Nova, making it a reliable option.
Research and Studies Are Proving Results
In a 68-week medical study of 1,961 adults dealing with obesity or excess weight with a related medical problem, the adults achieved an average of a 15% weight loss. This amounts to 35 pounds on the starting average of 232 pounds.
The time it takes to lose weight using Wegovy® can vary. One study showed that people lost an average of 6% of their starting body weight by 12 weeks, 10% by 20 weeks, and 15% in one year. The patients used Wegovy in combination with healthy nutrition and increased physical activity.
In separate trials, semaglutide has been shown to help people with obesity lose about 15% of their body weight.
Yet in a current study, which included 938 participants, about 20% of those on the maximum dose suffered some nausea, 20% diarrhea and 13% vomiting, which is lower than rates usually seen with comparable doses of semaglutide.
Possible Side Effects of Wegovy
Possible serious side effects of Wegovy include pancreatitis, gallbladder problems and kidney problems, among some other issues, according to the manufacturer. It also carries the warning that semaglutide causes thyroid C-cell tumors in rodent tests, though it is yet unknown whether that can happen in humans.